Literature DB >> 11518106

Clinical analysis of community-acquired pneumonia in the elderly.

Y Kobashi1, N Okimoto, T Matsushima, R Soejima.   

Abstract

OBJECTIVE: To evaluate the clinical features, etiology, and outcome of patients over 65 years old hospitalized for community-acquired pneumonia. PATIENTS: Eighty-four patients (50 males, 34 females) hospitalized for community-acquired pneumonia in Kawasaki Medical School Kawasaki Hospital between April 1998 and March 2000.
RESULTS: Most of the patients had respiratory symptoms or signs, but over one-third also had atypical symptoms of pneumonia such as dyspnea, consciousness disturbance, and gastrointestinal symptoms. The causative microorganisms were identified in 48% of these patients. Streptococcus pneumoniae (13%), respiratory viruses (13%), Haemophilus influenzae (8%) and Mycobacterium tuberculosis (8%) were frequently identified, but Mycoplasma pneumoniae was less frequently noted in the elderly. Double infection was recognized in 19 % and a combination of some virus and bacteria in 13%. Treatment consisted of the administration of second or third generation cephalosporin antibiotics intravenously, because antibiotics had already been preadministered in 39%. The prognosis was poor (mortality rate 9%) for the elderly with community-acquired pneumonia despite mechanical ventilation in 8%.
CONCLUSIONS: Although the range of microorganisms causing community-acquired pneumonia differed slightly from that in previous reports; namely, lower frequency of Chlamydia pneumoniae and Legionella pneumophila, it is suggested that the initial antibiotic treatment should always cover S. pneumoniae and H. influenzae. In addition, since a prevalence of virus infections related to the increase in community-acquired pneumonia in the elderly was found in this study, the routine use of influenza vaccine and pneumococcal vaccines in the elderly is recommended to reduce the high mortality rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518106     DOI: 10.2169/internalmedicine.40.703

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  Hospital Treatment Costs and Factors Affecting These Costs in Community-Acquired Pneumonia.

Authors:  Fatma Tokgöz Akyıl; Armağan Hazar; İpek Erdem; Canan Pehlivan Öneş; Murat Yalçınsoy; İlim Irmak; Umut Sabri Kasapoğlu
Journal:  Turk Thorac J       Date:  2015-07-01

Review 2.  The diagnosis of viral respiratory disease in older adults.

Authors:  H Keipp Talbot; Ann R Falsey
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

3.  New respiratory viruses and the elderly.

Authors:  Laura Jartti; Henriikka Langen; Maria Söderlund-Venermo; Tytti Vuorinen; Olli Ruuskanen; Tuomas Jartti
Journal:  Open Respir Med J       Date:  2011-07-06

4.  Respiratory tract virus infections in the elderly with pneumonia.

Authors:  Matti Aronen; Laura Viikari; Ia Kohonen; Tytti Vuorinen; Mira Hämeenaho; Maarit Wuorela; Mohammadreza Sadeghi; Maria Söderlund-Venermo; Matti Viitanen; Tuomas Jartti
Journal:  BMC Geriatr       Date:  2019-04-16       Impact factor: 3.921

5.  Viral pathogens among elderly people with acute respiratory infections in Shanghai, China: Preliminary results from a laboratory-based surveillance, 2012-2015.

Authors:  Chuchu Ye; Weiping Zhu; Jianxing Yu; Zhongjie Li; Yifei Fu; Yajia Lan; Shengjie Lai; Yuanping Wang; Lifeng Pan; Qiao Sun; Genming Zhao
Journal:  J Med Virol       Date:  2017-07-06       Impact factor: 2.327

Review 6.  Community-acquired viral pneumonia.

Authors:  Ann R Falsey
Journal:  Clin Geriatr Med       Date:  2007-08       Impact factor: 3.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.